Skip to main content

Security report for biotek.com

Agilent Technologies · Healthcare · N/a

Medium risk. 4 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

74/100

Risk levelMedium

0–100, higher is better. How it is calculated

Agilent Technologies operates a professional and comprehensive website focused on life science instrumentation, specifically microplate instrumentation under the BioTek brand. The company is positioned as a global leader with over 50 years of experience, targeting scientific research and clinical laboratory markets. The website demonstrates a mature digital presence with modern technologies and a clear business focus. Technically, the site uses a robust tech stack including Bootstrap, jQuery UI, Adobe DTM, and Coveo search, supported by multiple analytics and marketing tools. Security posture is strong with HTTPS, security headers, and cookie consent mechanisms, though explicit security policies and incident response information are not publicly detailed. The WHOIS data is unavailable, likely due to privacy protection, but the website's branding and content strongly support legitimacy. Overall, the site is professional, secure, and compliant with privacy regulations, serving an enterprise-level audience effectively.

Scanned

NIS2 and GDPR posture

GDPR outside view
73/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching biotek.com

This scan found 16 issues across 5 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
57
Security headers
30
Email security
100
DNS health
85
Network security
100
GDPR outside view
73
Average
74

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Agilent Technologies is a well-established enterprise in the healthcare and technology sectors, specializing in scientific instrumentation. Their business model is B2B, serving research institutions, clinical labs, and pharmaceutical companies. The company leverages a strong brand presence and a broad product portfolio, including BioTek microplate instruments. The website reflects a strategic focus on digital marketing and customer engagement through advanced search and analytics tools. Partnerships with advertising networks and use of consent management indicate compliance and marketing sophistication. The lack of direct contact emails or phone numbers in the HTML suggests a controlled communication approach, likely funneling inquiries through contact forms or regional pages. The company maintains a consistent brand image and targets a global audience with multilingual support.

Security posture

The website enforces HTTPS and implements multiple security headers, indicating a strong baseline security posture. Cookie consent is managed via OneTrust, supporting GDPR compliance. No exposed sensitive data or vulnerable libraries were detected in the provided content. However, the absence of a public security policy or vulnerability disclosure program limits transparency. Incident response contact information is not found, which could be improved to enhance trust and readiness. The use of multiple third-party scripts necessitates ongoing security audits to mitigate supply chain risks. Overall, the site demonstrates good security hygiene but could benefit from enhanced security communication and disclosure practices.

Recommendations

  1. Publish a dedicated security policy and incident response page to improve transparency.
  2. Implement and publicize a vulnerability disclosure program or security.txt file.
  3. Enhance mobile optimization and accessibility to improve user experience across devices.
  4. Provide clear and direct contact information for security and customer support.
  5. Regularly review and update third-party scripts to minimize security risks.

Contact details published on the site

Addresses
Legal name
Agilent Technologies
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Agilent Technologies
Description
BioTek Instruments began manufacturing microplate instrumentation in 1981 and has since evolved into a global leader in life science instrumentation.
Key services
Microplate instrumentation, Life science analytical instruments, Laboratory automation
Content quality
good
Branding
consistent

Technology

Stack
HTML5, CSS3, JavaScript, jQuery UI, Bootstrap, Coveo Search, Adobe DTM, Dynatrace monitoring, OneTrust cookie consent
Frameworks
Bootstrap
Platforms
Web
Performance
moderate
Mobile
basic
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent implemented
  • No exposed sensitive data in HTML
  • Use of security headers

Analytics and tracking

Services
Crazy Egg, Bing Ads, Google Tag Manager, Dynatrace
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Crazy Egg, Bing Ads, StackAdapt
Tracking pixels
LinkedIn Insight, Bing Ads
Marketing tools
Adobe DTM, Coveo Search
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Content is relevant to life science instrumentation and laboratory products.
  3. No direct company contact emails or phone numbers found in the provided HTML snippet.
  4. Comprehensive cookie and privacy policies implemented with consent mechanisms.
  5. Use of multiple third-party analytics and marketing tools with consent.
  6. No security.txt or explicit security policy pages found.
  7. WHOIS data unavailable, likely due to privacy protection.
  8. No signs of adult or questionable content.
  9. No WAF or blocking mechanisms detected.
Technical notes

Notes

The website employs a modern and diverse technology stack including Bootstrap for responsive design, jQuery UI for UI components, Adobe DTM for tag management, and Coveo for search functionality. Performance appears moderate with multiple asynchronous scripts and external resources. Mobile optimization is basic, with viewport settings and conditional scripts for mobile devices. Accessibility features are present but could be improved. SEO is supported by proper meta tags and structured data. Hosting details are not explicit but likely enterprise-grade given the scale and technologies used. Technical risks include dependency on multiple third-party services and potential complexity in script management.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with biotek.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review biotek.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.